JP2024515827A5 - - Google Patents
Info
- Publication number
- JP2024515827A5 JP2024515827A5 JP2023566512A JP2023566512A JP2024515827A5 JP 2024515827 A5 JP2024515827 A5 JP 2024515827A5 JP 2023566512 A JP2023566512 A JP 2023566512A JP 2023566512 A JP2023566512 A JP 2023566512A JP 2024515827 A5 JP2024515827 A5 JP 2024515827A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- modified
- acid according
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181059P | 2021-04-28 | 2021-04-28 | |
| US63/181,059 | 2021-04-28 | ||
| PCT/US2022/026805 WO2022232442A2 (en) | 2021-04-28 | 2022-04-28 | Multiplex crispr/cas9-mediated target gene activation system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515827A JP2024515827A (ja) | 2024-04-10 |
| JP2024515827A5 true JP2024515827A5 (https=) | 2025-05-20 |
Family
ID=83848892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566512A Pending JP2024515827A (ja) | 2021-04-28 | 2022-04-28 | 多重ＣＲＩＳＰＲ／Ｃａｓ９媒介標的遺伝子活性化システム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209354A1 (https=) |
| EP (1) | EP4330375A4 (https=) |
| JP (1) | JP2024515827A (https=) |
| CN (1) | CN117580941A (https=) |
| AU (1) | AU2022267320A1 (https=) |
| CA (1) | CA3218209A1 (https=) |
| WO (1) | WO2022232442A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025111340A1 (en) * | 2023-11-20 | 2025-05-30 | William Marsh Rice University | Engineered extrachromosomal nucleic acids and methods of use thereof |
| WO2025227064A1 (en) * | 2024-04-26 | 2025-10-30 | Renasci Biotechnologies, Inc. | Genomic editing methods to treat cardiovascular disease, and compositions for use in practicing the same |
| CN119020323A (zh) * | 2024-09-29 | 2024-11-26 | 中国农业科学院作物科学研究所 | 一种融合外切酶的CRIPSR/Cas12i3小麦基因编辑体系 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6793547B2 (ja) * | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| AU2017219605B2 (en) * | 2016-02-15 | 2023-04-13 | Temple University - Of The Commonwealth System Of Higher Education | Excision of retroviral nucleic acid sequences |
| AU2018393050A1 (en) * | 2017-12-21 | 2020-06-18 | Bayer Healthcare Llc | Materials and methods for treatment of Usher Syndrome Type 2A |
| WO2019236081A1 (en) * | 2018-06-06 | 2019-12-12 | Salk Institute For Biological Studies | Targeted gene activation using modified guide rna |
| EP4028063A1 (en) * | 2019-09-13 | 2022-07-20 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems delivered by lipid nanoparticles |
-
2022
- 2022-04-28 WO PCT/US2022/026805 patent/WO2022232442A2/en not_active Ceased
- 2022-04-28 CA CA3218209A patent/CA3218209A1/en active Pending
- 2022-04-28 AU AU2022267320A patent/AU2022267320A1/en active Pending
- 2022-04-28 JP JP2023566512A patent/JP2024515827A/ja active Pending
- 2022-04-28 US US18/288,772 patent/US20240209354A1/en active Pending
- 2022-04-28 CN CN202280046611.2A patent/CN117580941A/zh active Pending
- 2022-04-28 EP EP22796760.1A patent/EP4330375A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515827A5 (https=) | ||
| US20260009050A1 (en) | Anellosomes for delivering secreted therapeutic modalities | |
| JP2024083479A5 (https=) | ||
| JP2020508685A5 (https=) | ||
| WO2024119625A1 (zh) | 双链rna的合成方法及rna连接酶在双链rna合成中的应用 | |
| JP2023544683A5 (https=) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| JP2024531486A (ja) | 環状ｒｎａを調製するための構築物及び方法 | |
| JP2021507682A5 (https=) | ||
| JP2024520528A5 (https=) | ||
| CA3121528A1 (en) | Anellosomes and methods of use | |
| US20240254464A1 (en) | Cleavage-inactive cas12f1, cleavage-inactive cas12f1-based fusion protein, crispr gene-editing system comprising same, and preparation method and use thereof | |
| US20210380641A1 (en) | Self-assembling protein structures and components thereof | |
| CA3119814A1 (en) | Anellosomes for delivering protein replacement therapeutic modalities | |
| US20250223592A1 (en) | Compositions and methods for circular rna affinity purification | |
| CA3119339A1 (en) | Anellosomes for delivering intracellular therapeutic modalities | |
| JP2024523394A5 (https=) | ||
| PY2205136A (es) | Efecto sinérgico de smn1 y mir-23a en el tratamiento de la atrofia muscular espinal | |
| WO2019079819A1 (en) | COMPOSITION AND METHOD FOR ACTIVATION OF LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) | |
| WO2023227124A1 (zh) | 一种构建mRNA体外转录模板的骨架 | |
| WO2024251229A9 (zh) | Cas酶及其系统和应用 | |
| JP2024503091A5 (https=) | ||
| TW202221126A (zh) | 用於鑑別及特徵化指環病毒之方法及其用途 | |
| JP2025535373A (ja) | Ｃａｓタンパク質及び細菌毒素を含む融合タンパク質及びその使用 |